InsiderTrades

Form 4 for ELVN Enliven Therapeutics, Inc.

Accepted 2024-04-15 00:00:00 ET · period of report 2024-04-11 · accession 0001415889-24-010825 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-04-15 2024-04-11+ ELVN Heyman Richard A. Dir S - Sale $24.02 -6,315 137.2K -4% -$151.7K
I 2024-04-15 2024-04-11 ELVN Heyman Richard A. Dir S - Sale $25.00 -649 28.6K -2% -$16.2K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-04-15 S D 1,190 $19.94 137,235 D — — (F3) This transaction was executed in multiple trades at prices ranging from $19.61 to $20.5558. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
2 Common Common Stock 2024-04-11 S D 649 $25.00 28,567 I See footnote — — (F5) The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member.
3 Common Common Stock 2024-04-11 S D 5,045 $25.03 138.43 D — — (F2) This transaction was executed in multiple trades at prices ranging from $25.00 to $25.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
4 Common Common Stock 2024-04-15 S D 80 $20.68 137,155 D — — (F4) This transaction was executed in multiple trades at prices ranging from $20.64 to $20.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.